|
Join Us with guest: Karl Kappeler, MS, RPh, FASHP
Director, Medical Affairs of Azurity Pharmaceuticals.
and will be discussing C. difficile infections, C. diff. treatment options and the Azurity Pharmaceuticals organization with its FDA approved product.
Listen in as we learn more about the Company’s history, their unique product offerings that help pharmacists
compound drugs, and product information for FIRVANQ, their FDA approved vancomycin
oral solution.
|
